751 related articles for article (PubMed ID: 27462301)
21. Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses.
Dierikx CM; van Duijkeren E; Schoormans AH; van Essen-Zandbergen A; Veldman K; Kant A; Huijsdens XW; van der Zwaluw K; Wagenaar JA; Mevius DJ
J Antimicrob Chemother; 2012 Jun; 67(6):1368-74. PubMed ID: 22382469
[TBL] [Abstract][Full Text] [Related]
22. Emergence of
Ibrahim ME; Algak TB; Abbas M; Elamin BK
Exp Ther Med; 2021 Dec; 22(6):1450. PubMed ID: 34721692
[TBL] [Abstract][Full Text] [Related]
23. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM).
Cuzon G; Naas T; Bogaerts P; Glupczynski Y; Nordmann P
J Antimicrob Chemother; 2012 Aug; 67(8):1865-9. PubMed ID: 22604450
[TBL] [Abstract][Full Text] [Related]
25. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.
Pitout JD; Gregson DB; Campbell L; Laupland KB
Antimicrob Agents Chemother; 2009 Jul; 53(7):2846-51. PubMed ID: 19380595
[TBL] [Abstract][Full Text] [Related]
26. Distribution of
Abrar S; Ain NU; Liaqat H; Hussain S; Rasheed F; Riaz S
Antimicrob Resist Infect Control; 2019; 8():80. PubMed ID: 31139363
[TBL] [Abstract][Full Text] [Related]
27. Integron-mediated multidrug resistance in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from fecal specimens in Egypt.
Elsherif RH; Ismail DK; El-Kholy YS; Gohar NM; Elnagdy SM; Elkraly OA
J Egypt Public Health Assoc; 2016 Jun; 91(2):73-9. PubMed ID: 27455084
[TBL] [Abstract][Full Text] [Related]
28. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from the rivers and lakes in Northwest China.
Liu H; Zhou H; Li Q; Peng Q; Zhao Q; Wang J; Liu X
BMC Microbiol; 2018 Oct; 18(1):125. PubMed ID: 30286725
[TBL] [Abstract][Full Text] [Related]
29. High occurrence of CMY-2-type beta-lactamase-producing Escherichia coli among broiler flocks in Turkey.
Aslantaş Ö
Trop Anim Health Prod; 2020 Jul; 52(4):1681-1689. PubMed ID: 31858371
[TBL] [Abstract][Full Text] [Related]
30. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.
Zhang J; Zheng B; Zhao L; Wei Z; Ji J; Li L; Xiao Y
BMC Infect Dis; 2014 Dec; 14():659. PubMed ID: 25466590
[TBL] [Abstract][Full Text] [Related]
31. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
32. First detection of CTX-M-1, CMY-2, and QnrB19 resistance mechanisms in fecal Escherichia coli isolates from healthy pets in Tunisia.
Sallem RB; Gharsa H; Slama KB; Rojo-Bezares B; Estepa V; Porres-Osante N; Jouini A; Klibi N; Sáenz Y; Boudabous A; Torres C
Vector Borne Zoonotic Dis; 2013 Feb; 13(2):98-102. PubMed ID: 23289399
[TBL] [Abstract][Full Text] [Related]
33. Diversity of genetic lineages among CTX-M-15 and CTX-M-14 producing Escherichia coli strains in a Tunisian hospital.
Ben Slama K; Ben Sallem R; Jouini A; Rachid S; Moussa L; Sáenz Y; Estepa V; Somalo S; Boudabous A; Torres C
Curr Microbiol; 2011 Jun; 62(6):1794-801. PubMed ID: 21479796
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and characterization of extended-spectrum beta-lactamase (ESBL)- and CMY-2-producing Escherichia coli isolates from healthy food-producing animals in Tunisia.
Ben Sallem R; Ben Slama K; Sáenz Y; Rojo-Bezares B; Estepa V; Jouini A; Gharsa H; Klibi N; Boudabous A; Torres C
Foodborne Pathog Dis; 2012 Dec; 9(12):1137-42. PubMed ID: 23194332
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and Molecular Epidemiology of ESBL-, AmpC-, and Carbapenemase-Producing
Sepp E; Andreson R; Balode A; Bilozor A; Brauer A; Egorova S; Huik K; Ivanova M; Kaftyreva L; Kõljalg S; Kõressaar T; Makarova M; Miciuleviciene J; Pai K; Remm M; Rööp T; Naaber P
Front Microbiol; 2019; 10():2465. PubMed ID: 31824436
[TBL] [Abstract][Full Text] [Related]
36. Aeromonas spp. simultaneously harbouring bla(CTX-M-15), bla(SHV-12), bla(PER-1) and bla(FOX-2), in wild-growing Mediterranean mussel (Mytilus galloprovincialis) from Adriatic Sea, Croatia.
Maravić A; Skočibušić M; Samanić I; Fredotović Z; Cvjetan S; Jutronić M; Puizina J
Int J Food Microbiol; 2013 Sep; 166(2):301-8. PubMed ID: 23973842
[TBL] [Abstract][Full Text] [Related]
37. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
[TBL] [Abstract][Full Text] [Related]
38. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
39. Fecal Carriage of Extended-Spectrum-β-Lactamase/AmpC-Producing
Hordijk J; Farmakioti E; Smit LAM; Duim B; Graveland H; Theelen MJP; Wagenaar JA
Appl Environ Microbiol; 2020 Apr; 86(8):. PubMed ID: 32033947
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.
Peirano G; van Greune CH; Pitout JD
Diagn Microbiol Infect Dis; 2011 Apr; 69(4):449-53. PubMed ID: 21396544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
